SOFTMAX CO.,LTD
3671・Standard Market・Information & Communication
Business
SOFTMAX CO.,LTD. was founded in 1974, changed to its current company name in 2001, and listed on the Tokyo Stock Exchange in 2013 (transitioning to the Standard Market in December 2025). It is a company specializing exclusively in medical information systems. Its core products are the "PlusUs" series of comprehensive medical information systems, centered on the in-house developed Web-based Electronic Medical Record System "PlusUs-Karte," which integrates electronic medical records, ordering, medical accounting, and departmental support systems into a unified offering. Targeting a wide range of medical institutions from general hospitals to clinics, the company operates a direct sales system covering Kyushu, Chugoku, Shikoku, Kinki, Chubu, Kanto, Tohoku, and Hokkaido through 16 locations nationwide. The company is promoting cloud-based provision (public and private) and has established a 24-hour remote support system.
Business Model
Revenue is composed of three categories: software sales (FY2025: ¥2,911 million, 42% of composition), hardware sales (¥2,099 million, 30%), and Maintenance Services, etc. (¥1,919 million, 28%). The company provides development, sales, installation, and maintenance in an integrated production-sales structure, with a recurring-revenue base in which maintenance service revenue expands steadily as the cumulative number of installations grows. Through the promotion of migration to a cloud-based provision model, the company aims for a structure that secures continuous revenue while reducing customers' initial and operating costs.
Company Strengths
In FY2025, net sales reached ¥6,929 million (up 27.6% year on year), operating profit was ¥741 million (up 11.8%), and net income was ¥573 million (up 19.4%), marking record highs since listing across all key metrics including net sales, operating profit, ordinary profit, and net income. Capturing Medical DX-related demand and securing large-scale orders drove the results.
The company began developing and selling a Web-based electronic medical record system in 2011, which, unlike client-server systems, eliminates the need for an on-site system administrator and reduces initial costs. It is offered in both public cloud and private cloud formats, appealing to customers through improved efficiency of information sharing between medical institutions and enhanced disaster resilience. The company has obtained ISO9001, ISO27001, and Privacy Mark certifications to ensure quality and security.
In FY2025, sales of Maintenance Services, etc. reached ¥1,919 million (up 18.1% year on year), continuing stable growth as the cumulative number of installations increased. Accounting for approximately 28% of total net sales, this recurring revenue forms a business foundation that is relatively unaffected by economic fluctuations. A 24-hour remote support system contributes to maintaining customer retention rates.
ENVALITH's Perspective
Performance Trend
Revenue over the past five fiscal years progressed as follows: ¥4,489 million (FY2021) → ¥5,050 million → ¥5,261 million → ¥5,429 million → ¥6,929 million (FY2025), marking five consecutive years of revenue growth. For the cumulative first quarter of FY2026 (ending December 2026), revenue reached ¥2,295 million (up 70.5% year-on-year), recording accelerated revenue growth. However, cost of sales grew to ¥1,788 million (up 106.7% year-on-year), outpacing revenue growth, causing the gross profit margin to decline sharply from 35.8% in the same quarter of the prior year to 22.1%. The main drivers of the cost increase were strengthening of personnel structure and investment in new feature development. As an external factor, demand related to the promotion of medical DX policy and response to fee schedule revisions has been pushing up revenue, while at the same time rising costs continue to weigh on profits. For the full fiscal year, operating profit is forecast at ¥800 million (up 8.0% year-on-year), which is premised on a recovery in profitability in the second half.
Growth Strategy
Leveraging Medical DX policy and revisions to medical service fees as tailwinds, expanding market share through cloud, AI, and enhanced security
Deploying public cloud services registered on the ISMAP Cloud Service List and private cloud services for group hospitals, capturing demand for new installations and replacements while differentiating from competitors. Software sales in the first quarter of FY2026 (ending March 2026) grew substantially, up 203.1% year-on-year.
Promoting pilot tests of advanced technologies, including generative AI, aimed at supporting document creation and improving operational efficiency in medical settings. Aiming to advance progressive medical projects through strengthened collaboration with other companies, with a view to improving customer satisfaction and developing new value-added services.
Continuously expanding the development, sales, installation, and maintenance of Medical DX-related Systems (Generative AI and Other Advanced Technologies), in anticipation of progress in establishing the "Nationwide Medical Information Platform" infrastructure and the nationwide rollout of the electronic medical record information sharing service within FY2026 (ending March 2026). Actively investing in strengthening personnel systems and developing new functionalities.
Advancing the transition to electronically recorded monetary claims in response to the government's policy to abolish paper-based promissory note transactions by the end of FY2026 (ending March 2026). As of the end of the first quarter of FY2026 (ending March 2026), electronically recorded monetary claims of ¥397 million were recorded, indicating progress in the electronic conversion of transactions.
Last updated: July 17, 2026